advertisement
Zhang Q 99
Showing records 1 to 25 | Display all abstracts from Zhang Q116992 Intracellular Zn promotes extracellular matrix remodeling in dexamethasone-treated trabecular meshwork
Liu C
American Journal of Physiology and Cell Physiology 2024; 326: C1293-C1307
117099 Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial
Feng H
Translational vision science & technology 2024; 13: 21
117779 Assessment of Causality Between Diet-Derived Antioxidants and Primary Open-Angle Glaucoma: A Mendelian Randomization Study
Xiong K
Translational vision science & technology 2024; 13: 20
117059 Correlation of contrast sensitivity with ganglion cell/inner plexiform layer thickness and damage location in glaucoma with varying severity
Pang R
Eye 2024; 38: 1308-1313
118274 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Patil SV
Scientific reports 2024; 14: 6958
117083 Quantitative analysis of dynamic iris changes in primary angle-closure disease with long axial lengths: the Handan Eye Study
Wang J
Eye 2024; 38: 1362-1367
118571 Effects and potential mechanisms of exercise and physical activity on eye health and ocular diseases
Zhang Q
Frontiers in medicine 2024; 11: 1353624
118462 Analysis of research hotspots and trends in pediatric ophthalmopathy based on 10 years of WoSCC literature
Jia Q
Frontiers in pediatrics 2024; 12: 1405110
117308 Performance of Artificial Intelligence Chatbots on Glaucoma Questions Adapted From Patient Brochures
Yalla GR
Cureus 2024; 16: e56766
117139 Characteristics of beta parapapillary atrophy in primary angle-closure suspect
Xiang F
BMJ open ophthalmology 2024; 9:
117442 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Patil SV
Research square 2023; 0:
118571 Effects and potential mechanisms of exercise and physical activity on eye health and ocular diseases
Jiang Y
Frontiers in medicine 2024; 11: 1353624
117442 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Kaipa BR
Research square 2023; 0:
117308 Performance of Artificial Intelligence Chatbots on Glaucoma Questions Adapted From Patient Brochures
Hyman N
Cureus 2024; 16: e56766
116992 Intracellular Zn promotes extracellular matrix remodeling in dexamethasone-treated trabecular meshwork
Tang J
American Journal of Physiology and Cell Physiology 2024; 326: C1293-C1307
117442 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Kaipa BR
Research square 2023; 0:
118462 Analysis of research hotspots and trends in pediatric ophthalmopathy based on 10 years of WoSCC literature
Wang X
Frontiers in pediatrics 2024; 12: 1405110
118274 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Kaipa BR
Scientific reports 2024; 14: 6958
117083 Quantitative analysis of dynamic iris changes in primary angle-closure disease with long axial lengths: the Handan Eye Study
Wang Y
Eye 2024; 38: 1362-1367
117099 Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial
Han D
Translational vision science & technology 2024; 13: 21
117779 Assessment of Causality Between Diet-Derived Antioxidants and Primary Open-Angle Glaucoma: A Mendelian Randomization Study
Zhang Q
Translational vision science & technology 2024; 13: 20
117139 Characteristics of beta parapapillary atrophy in primary angle-closure suspect
Zhang Y
BMJ open ophthalmology 2024; 9:
118274 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Kaipa BR
Scientific reports 2024; 14: 6958
117059 Correlation of contrast sensitivity with ganglion cell/inner plexiform layer thickness and damage location in glaucoma with varying severity
Peng J
Eye 2024; 38: 1308-1313
118274 Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
Ranshing S
Scientific reports 2024; 14: 6958
